Skip to main content
. 2025 Apr 10;2025:2702089. doi: 10.1155/cjgh/2702089

Figure 5.

Figure 5

Secondary endpoint (a) Improvement rate of edema (b) Improvement rate of redness (c) Improvement rate of hemorrhage (d) Improvement rate of gastrointestinal symptoms.